Format

Send to

Choose Destination
Cardiol Rev. 2012 Jul-Aug;20(4):197-207. doi: 10.1097/CRD.0b013e318248a3e1.

Growth hormone and the cardiovascular system.

Author information

1
Department of Medicine, Division of Endocrinology, New York Medical College, Valhalla, NY 10595, USA.

Abstract

Growth hormone (GH) exerts its effects through insulin-like growth factor-1, and although ubiquitous in human tissues, it has a significant role in cardiovascular function. In recent years, there has been a great deal of interest in GH as an etiologic factor in many cardiovascular disease states. Acromegaly, a state of endogenous GH excess, results in myocardial hypertrophy and decreased cardiac performance with increased cardiovascular mortality. Additional insight into the role of excess GH on the cardiovascular system has been gained from data collected in athletes doping with GH. Likewise, GH deficiency is associated with increased mortality, possibly from the associated increase in atherosclerosis, lipid abnormalities, and endothelial dysfunction. However, further research is required to clarify the benefit of GH treatment in both deficient states and in heart failure patients.

PMID:
22314142
DOI:
10.1097/CRD.0b013e318248a3e1
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center